Aaron Capital, Inc. (“Aaron”), a leading global middle market investment bank, is pleased to announce the equity investment into miVIP and Oband, Inc. (together “miVIP”, or the “Company”), one of the leading networks of outpatient surgery centers specializing in robotically assisted minimally invasive surgeries in the United States, by Shanghai Hongxiao Science and Technology Co., LTD. (“Hongxiao”), a China-based company.  The transaction is valued at up to $300 million including the initial payment and several future earnouts.


Founded in 2006, miVIP is owned by Dr. Isaac Verbukh.  Under his leadership the Company has expanded from a single location to six surgery centers and over 80 surgeons.  They perform a wide spectrum of surgical procedures including Bariatrics, Ear, Nose, and Throat (ENT), Gastroenterology, General Surgery, Gynecology, Joint Replacement, Orthopedics, Pain Management, Podiatry, Spinal Surgery, and Urology.  The Company is the largest group of surgical centers in the world to utilize the da Vinci Robotic Surgical System.


The investment banking team led by Tong Liu, Robert Smith and Roman LeFranc provided M&A and industry experience and worked closely with Dr. Verbukh and his management team throughout the sale process, including preparatory activities, marketing the company on a worldwide basis, due diligence and negotiation.  After evaluating multiple candidates, the team and Dr. Verbukh decided to choose Hongxiao to become miVIP’s future partner.  There were a number of contributing factors in miVIP selecting Hongxiao as its transaction partner, but the two most important were the Hongxiao’s willingness to support a continued aggressive expansion plan in the US, while also brining miVIP’s expertise and medical services worldwide.


Deal Team Contacts
Robert Smith, President / Partner 562.858.4141
Roman LeFranc, Managing Partner 310.413.8677
Tong Liu, Managing Partner 626.926.7588



Footer Menu